Drug Information

Drug General Information
Drug ID
D00YXE
Former ID
DNC005885
Drug Name
2-(5-chloro-1H-benzo[d]imidazol-2-yl)quinoxaline
Drug Type
Small molecular drug
Indication Discovery agent Investigative [527933]
Formula
C15H9ClN4
Canonical SMILES
C1=CC=C2C(=C1)N=CC(=N2)C3=NC4=C(N3)C=C(C=C4)Cl
InChI
1S/C15H9ClN4/c16-9-5-6-12-13(7-9)20-15(19-12)14-8-17-10-3-1-2-4-11(10)18-14/h1-8H,(H,19,20)
InChIKey
SOUPHJBGFDZRAD-UHFFFAOYSA-N
PubChem Compound ID
11652061
Target and Pathway
Target(s) Adenosine A3 receptor Target Info Inhibitor [527933]
Reactome Adenosine P1 receptors
G alpha (i) signalling events
WikiPathways Nucleotide GPCRs
GPCRs, Class A Rhodopsin-like
GPCRs, Other
References
Ref 527933J Med Chem. 2005 Dec 29;48(26):8253-60.2-(Benzimidazol-2-yl)quinoxalines: a novel class of selective antagonists at human A(1) and A(3) adenosine receptors designed by 3D database searching.
Ref 527933J Med Chem. 2005 Dec 29;48(26):8253-60.2-(Benzimidazol-2-yl)quinoxalines: a novel class of selective antagonists at human A(1) and A(3) adenosine receptors designed by 3D database searching.